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CHAPTER - 1 
INTRODUCTI0N 
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1.1. Sandwich compounds: 
 
 The sandwich complexes are organometallic compounds consisting of more than one 
cyclopentadienyl rings bonded to central metal atom in a variety of structural motif.  Different 
types of sandwich compounds are known for example metallocenes, half sandwich complexes, 
multidecker sandwich compounds, various arene type sandwich compounds etc (Figure 1). Some 
of these complexes are readily synthesized and shows unique properties like electrochemical, 
bioactivity, catalysis and other optoelectronics properties. 
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Figure 1: sandwich complexes 
 
Several titanium based sandwich compounds, [(η5-C5Me4R1)2Ti], (R1=iPr, tBu, SiMe3, 
SiMe2CH2CH2Ph, SiMe2Ph, SiMePh2) have been synthesized recently by different research 
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groups as shown in Figure 2.
1,2
  These titanocene compounds have 1,1’-disubstituted groups 
attached to each of the cp rings and has been used for the synthesis of other organometallic 
sandwich compounds. 
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Figure 2: [(η5-C5Me4R1)2Ti] (R1=SiMe3,SiMe2CH2CH2Ph,SiMe2Ph,SiMePh2) 
 
 
Zirconocene sandwich compounds have found widespread application as a two-electron 
reductant in several organic synthesis.
3 
  Dioumaev and Harrod reported the addition of n-BuLi 
to (η5-C5H5)2ZrCl2 in the absence of any substrate leading to the formation of [Cp2Zr(n-Bu)2] 
which subsequently affords paramagnetic butylzirconocene(III), zirconocene(III) hydride and 
diamagnetic butenylzirconocene(IV) hydride dimer in multistep reaction.
4
 ( Scheme 1). 
 When [(η5-C5Me5)2ZrCl2] reacted with sodium amalgam reductase under an atmosphere 
of N2 it produces a dinitrogen complpex, [(η
5
-C5Me5)2Zr(η
5
-N2)]2(µ2, η
1, η1-N2)].  Treatment of 
the Zirconium-dinitrogen complex with mineral acid results in the formation of free hydrazine.
5  
(Scheme 3)  
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1.2 FERROCENE CONTAINING COMPOUNDS : 
 Ferrocenyl compounds have been extensively studied in recent years and it is gaining 
research importance as a substituent in medicinal chemistry due to some of its unique properties 
and stability.  These compounds illustrate anticancer, antimalarial and other biological activity 
due to lipophilicity and electronic effects and other interesting properties of the ferrocene ring 
associated with the substitutents.  Recently a groups of ferrocenyl chalcones related with 
aromatic and polycyclic compounds such as ferrocene
6
, naphthalene
7
 and anthracene
8
 are studied 
because these systems were designed in order to modulate the electrochemical and optical 
properties of the polycyclic moieties by the electron donating ferrocenyl group through the enone 
linkage (Figure 3) 
Fe
O
Fc-Naph
Fe
O
Fc-Anth
Fe
O
Fe
Fc-Fc  
Figure 3  
The optical properties of the naphthalene and anthracene moieties were quenched by the 
ferrocenyl moiety which acts as a quencher
9
.  Some ferrocenyl derivative have been reported to 
show interesting  electrochemical and spectroscopic properties
,10
. 
Ferrocene skeleton is extensively applied in biological systems and it is used in the design of 
drugs
 
because of being readily recognized by amino acids, proteins, DNA, and carbohydrates in 
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vivo
11
.  Ferrocene-related organometallic compounds are active to hamper the proliferation of 
many kinds of tumor cells.  Ferrocene is incorporated because it may be combined with organic 
moieties to form conjugation and non-conjugation systems.  As for example, ferrocifen can be 
prepared by replacing one benzene ring in tamoxifen, in which the cyclopentadienyl ring (Cp) 
forms a conjugation system with other benzene rings
12,13
.  On the other hand, in ferrocene 
cyclopentadienyl  (Cp) ring can connect with  the carbon chain in chloroquine to generate 
ferroquine where the ferrocenyl moiety forms a non-conjugation system in ferroquine
14,15
.   
 
1.3 CHALCONES: 
 Chalcones [(Ar–COCH=CH–Ar’) ] are the aromatic ketone and also an enone which 
forms the central core for a variety of important biological compounds.  Chalcones are present in 
nature as precursors of flavionoids and it is also considered as precursors of isoflavionoids
16
   
Chalcone functionating group present in some derivatives of flavionoids (Figure 4).   
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Figure 4    Chalcone containing compounds 
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Chalcones are readily synthesized in the laboratory by various synthetic methods.  Structural 
modification of chalcone template can be readily achieved.  Chalcones are present in edible 
plants and constitute one of the major classes of natural products with wide range distribution in 
fruits, vegetables, tea and soy based food stuff
17
.  Recent investigation shows that chalcones have 
been subjects for their interesting biological activities
18,19
.  The main functions of chalcone are 
purifying blood, strengthing immune system, monitors cholesterol level,  regulates blood 
pressure, prevents thrombus, suppress acid secretion,  prevent cancer and promotes metabolism.    
Most of the chalcones are prepared by the condensation of ketone with aromatic aldehyde 
following Claisen–Schmidt reaction20.   
 Recently some research groups prepared some chalcones compounds which are very 
reactive to nicotinohydrazide.resulting 1, 3, 5-trisubstitutedpyrazoline which show potential anti 
malarial activity of malaria parasite (Scheme 3).  
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1.4 Ferrocenyl chalcones 
 
Ferrocenyl chalcones belong to a chalcone family in which one or both the aromatic group is 
substituted by the ferrocenyl unit.  Some Ferrocenyl chalcones have been synthesized recently 
and shows a variety interesting properties due to the linking of ferrocenyl moiety to the chalcone 
framework.. Recent reports shows that. some ferrocenyl chalcones has been used as ligands 
leading to the formation of Hg complexes. These complexes showed interesting uv-visible 
spectroscopic properties ( Figure 5).
22
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Figure 5 . 
Like chalcone, ferrocenyl chalcone also very sensitive, resulting 3-ferrocenyl-pyrazole, 3-
ferrocenyl-pyrazoline, and byproduct (scheme 4).
23 
13 
 
Fe
O
OH
Fe
N N
Me
+ Fe
N N
Me +
Fe
N N
HO
NO2
A
B
C  
Scheme 4 
 
Recently ferrocenyl chalcones containing N-ethyl carbazole moiety has been reported by Dong-
Young Noh which is designed to modulate the electrochemical and optical properties of the 
polycyclic moieties by the electron donating ferrocenyl group through the enone linkage
24 
. 
Several other ferrocene-containing chalcones [Fc-CO-CH=CH-C6H4] (R = OCH3, CH3, Ph, tBu, 
H, Br and CF3) has been investigated based on their electrochemical and spectroscopical 
behavior as well as with DFT calculations (Figure 6 ).  These compounds were prepared by 
Claisen-Schmidt condensation of acetylferrocene and the appropriate benzaldehyde derivative 
under room temperature stirring condition.  The redox potential of the Fc/Fc+ couple depends on 
the electronic properties of the ligands which are being bonded to the cyclopentadienyl rings
25
. 
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Fe
O
R
R = OCH3, CH3, C6H5, 
tBu, H, Br, CF3  
Figure 6 
 Synthesis of disbstituted ferrocenyl chalcones have been carried out by the condensation of 1,1′-
diacetylferrocene with benzaldehyde, vanillin, and protocatechualdehyde, respectively, to 
produce 1,1′-dicinnamoylferrocene, 1-acetyl-1′-(m-methoxyl-p-hydroxyl)cinnamoylferrocene 
(VAN-1), 1,1′-bis(m-methoxy-p-hydroxy)cinnamoylferrocene (VAN-2), and 1-acetyl-1′-(m,p-
dihydroxy)cinnamoylferrocene (PCA-1) (Scheme 5).  
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Scheme 5. Derivative of ferrocenyl chalcone 
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1.5. BIOLOGICAL ACTIVITIS:-      
1.5.1. ANTI-BACTERIAL ACTIVITY 
 Chalcones are known to show substantial antibacterial activity
26
.  Many research groups 
are engaged to identify the structure of chalcones that possess antibacterial activity,or 
synthesized or modified natural chalcones.  Among the retro-chalcones licochalcone A and 
licochalcone B showed potent antibacterial activity especially to Bacillus S ubtills, Micrococcus 
luteus, Staphylococcus aureus.  Tsukiyama et. al. first reported the bacterial effects of 
licochalcone A
27
. 
  It was shown by MICs of 2-15µg/ml for gram positive bacteria including spore forming 
bacteria like (the genera Bacillus coagulans,B.subtills and Bacillus sterothermophilus=>MIC 
=2µg/ml
28
;toxin producing bacteria such as Bacillus cerous MIC=3µg/ml).The antibacterial 
activity of licochalcone A was defiant to 800 to 120
0
c for 15 minutes,and it is stable at pH 5.0 to 
pH 7.0
29
.  It was reported  that  licochalcone A shows antibacterial activity in the presence of 3% 
(wt/vol) NaCl.  According to Friis-Moller and calleagues, at concentration of 1-2 mg l
-1
 the 
licochalcone A repressed the growth of Legionella pneumophila, Legionella wardsworthii, 
Legionella bozemanii, Legionella dumoffi ,Legionella feelei.  It was recorded that free hydroxide 
on 4
th
 position of the ring was necessary for the anti bacterial activity
30
. 
O
HO
OCH3
OH
Licochalcone C
CH3
CH3
O
OCH3
OH
CH3
CH3
HO
Licochalcone A
 
 
Figure 7 
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1.5.2.   ANTI-LEISHMANIAL ACTIVITY:- 
Leishmaniasis is a group of common disease which is caused by protozoan parasites belonging to 
the genus Leishmania.  Various research work has been going on to prevent this disease. 
Licochalcone A is one of the naturally occurning chalcone under this investigation.  Various 
types of diseases are caused by Laishmania majorto (skin disease). 
It has been reported by Chen et.al that licochalcon A reserved the activities of nicotinamide 
adenine dinucleotide reduced-fumarate reductase ( NADH-FRD) AND succnate dehydrogenase 
(SAD) in permeabilized promastigotes in a concentration dependent manner
31
. 
This compound also reserved the activities of SDH,NADH dehydrogenase (NAD) , SCC, 
NADH-NCC.  In mammalion cells IC5os of licochalcone A for SDH were present 67 times 
higher than the IC  for FRD in the parasites.  The effect of Licochalcone A depends on time and 
concentration
32
.  It is evedent that the Licochalcone A first inhibits FRD of the parasite , then it 
influence the parasite respiratory chain and after that it affects the function and ultra structure of 
parasite mitrocondria.  And atlast kills the parasite.  Licochalcone C helps for growthing the L. 
Major parasite as like as Licochalcone A.  The chalcone and chloro chalcone depends on the 
concentration effect.It affect on the in vitro growth of Leishmania braziliensis Promastigotes and 
on Trypanosoma cruzi epimastigotes without any evidence of a cytotoxic effect on mouse 
peritoneal macrophages. 
2
’
 ,6’ –Dihydroxy-4’ –methoxy chalcone has an important activity in vitro against promastigotes 
and intracellur amastigotes of Leishmania amazonensis , with 50% effective doses of 0.5 µM/ml 
and 24µM/ml respectively
33
.2 ,6 –Dihydroxy-4 –methoxy chalcone is very much toxic to the 
parasite.Various hydrochalcone derivaties were prepared by Hermoso et al.
34
   
 
1.5.3.  ANTI-MALARIAL ACTIVITY :- 
It  is found to be  lipophilic and has electron donating entity with no hydrogen bond donor or 
acceptor property.The ferrous ion can undergo reversible oxidation–reduction and the nature of 
the substituents on the ferrocene ring has a marked influence on  the antimalarial propertys.
35   
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The two important human being malaria parasites are Plasmodium falciparum and P. It is seen 
that in  a ferrocenyl compound, ‘Ferroquine’ synthesized by the replacement of a CH2 group in 
the anti-malarial chloroquine  is active against both chloroquine-sensitive and 
chloroquine-resistant Plasmodium falciparum, and is currently in Phase II clinical trials  
Chalcones have antimalarial activity, because of a Michael addition of nucleophilic species to the 
double bond of the enone
36,37
.  It was recorded by Liu et al.
38
 and Go et al. that in vitro 
antimalarial properties of chalcones against a strain of chloroquinine-resistant human being 
malarial parasite,P. falciparum was mainly resolute by the properties of ring B.  Alkoxylated 
chalcones were more active than the hydoxylated analogues.  For alkoxylated chalcones the IC50 
value were less than 6.5 µM.  The most important hydoxylated chalcone was 4-chloro-2
’,4‘–
hydroxy chalcone  and its IC50 value was 12.3 µM against a strain of chloroquine-resistant 
human being malarial parasite , P. falcifarum. IC50 values for another few chalcones were  below 
20 µM.  These two chalcones were found to inhibit sorbitol-induced hemolysis ofparasitized 
erythrocytes to an important extent at a concentration of 10µM
39
. 
5-Prenylbutein,licoagrochalcone A and hemobutein had in vitro antiplasmodial activity against 
the chloro-quine sensitive
40
. 
O
OCH3
OH
HO
licoagrochalcone A
O
HO
OH
OH
OH
5-Prenylbutein  
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Figure 8 
Many sulfonamide chalcones contains di and tri methoxy substituted groups in aromatic ring A 
and it showed inhibition levels of β hematin formation with IC50 = 0.48µM and IC50=0.67. 
Cl
R
3
SO2NH
Cl
O
R
4
R
1
R
2
R
1
 = H; R
2
, R
3
, R
4
 = OCH3
R1, R3 = F; R2, R4 = H  
Figure 9 
Sulfonamide chalcones having one Cl, F, OCH3 or CH3 
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 group were less active than di or tri substituted analogues.  Groups of phenylurenyl chalcone 
derivatives with substitution were discovered by Dominguez et al
41
.  They reported that in most 
cases the activity was governed to a large extent by groups attached to the substituted aromatic 
ring A.   
In the groups of 4
’
-phenylurenyl chalcone derivatives the  para position in the urenyl ring plays 
an excellent role in antimalarial activity
42
.  But 4
’
-phenylurenyl chalcones were less reactive than 
3
’
-phenylurenyl chalcone derivatives.   
2,4-Dimethoxy-4
’
-butoxy chalcone was an important compound with outstanding antimalarial 
activities against in vitro and in vivo parasites without any toxicity
43
.  This compound had 
concentration dependent inhibitory effect on the hypoxanthine uptake of the chloro-quine  
susceptible and chloroquine resistant.  The IC50 valus were 8.9µM and 14.8µM respectively.   
O
HO
OH
OCH3
OH
 
Figure 10  Crotaorixin 
It was secluded from aerial parts of the Crotalaria orixensis exhibited 100% inhibition of 
maturation of Plasmodium falciparum parasite from ring stage to schizont stage both at 50 µg/ml 
and 10µg/ml concentration
44
.   
Medicagenin was the deprenylated compound
 
and has been recently isolated from the roots of 
Crotalaria.
45
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O
HO
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OH
 
Figure 11 Medicagenin 
Medicagenia inhibited the parasites 100% at 2µg/ml concentration while the chromenodihydro 
chalcones from crotalaria ramosissima showed lower activity.   
In vitro evaluation of 4
’
-tert-butylo-4-bromochalcone had the ebility to inhibitrecombinant P. 
falciparum iron superoxide dismutase it also had an important antimalarial activities against 
chloraquine-sensitive P. falciparum strain (IC50=37µM) and the chloroquine-resistant strains 
(IC50 =27µM)
46
 . 
Larsen et. Al
47
. recorded the antiplasmodial activity of two series of E and Z conformationlly 
restricted analogues and their parent chalcones against P. falciparum.  The Z conformation 
analogue with the double bond were some how inactive than the E conformation analogues.  It 
has been tasted by Frolich et al that in vitro antiplasmodial activity of prenylated chalcone 
derivatives from hops against the chloro-quine sensitive strain poW and the multiresistant clone 
Dd2 using a hypoxanthine-incorporation assay.   
Xanthohumal was the main hop chalcone  .It was the most active with IC50 valus of 8.2+0.3µM 
(poW) and 24.0+0.8µM (Dd2).   
 
 
 
21 
 
1.5.4. ANTI-FUNGAL ACTIVITY:- 
       Dermatophytes are generally known as a group of fungi it characteristically infect the 
keratinized areas of the body and dermatomycoses are very difficult to eradicate.  By various 
research work it is very exciting that the chalcone derivatives showed activity against 
dermatophytes of fungi.It has been reported by Lopez et al. that chalcones 13 - 16 against a panel 
of human opportunistic pathogenic fungi,using the Agar dilution method
48
.   
 
R3
O
R2
R1
13=> R1, R3= H; R2 = NO2
14=> R1=OCH3; R
2, R3=H
15=>R1 ,R3 =H ;R2 =CH3
16=>R1=OCH3; R
2=H; R3 =Br  
Figure 12 
The electron withdrawing groups in the para position increased the potency but electron donating 
donating groups decreased the antifungal activity.  For the presence of NO2 and Cl group in the 
ortho position the antifungal activity decreased ,that phenomenan proved that there was an steric 
effect which results from the size of substitution and the repultion between them. 
For the enone linkage , a structural requirement was necessary but not itself sufficient for the 
antifungal activity.  16 does not possess any electron withdrawing group in the para position of 
ring A and no substituent at ortho position. But it has strong antifungal activity against 
microsporum canis whose MIC value is 25µM/ml,microsporum gypseum (MIC=1.5µM/ml), 
Trichophyton rubrum (3µM/ml), Trichophyton floccosum (0.5µM/ml).It was observed that 2-
chloro-2
’
-hydroxy-4
’
-6
’
-dimethoxy-chalcone had the lowest MIC against T. rubrum.   
22 
 
Svetaz et. al. reported that the methanolic extract of Zuccagnia punctata having 2
’
,4
’
-dihydroxy 
chalcone (17) showed very good activity (MIC=6.25 and 3.12 µM/ml) against Phomopsis 
longicolla Hobbs CE117, and (MIC =6.25µM/ml) Colletotrichum truncatum CE 175 
respectively
47
.   
O
H
OH
H
OH
 
Figure 13 
Suman et al
48
 reported various substituted chalcones for their antifungal activity against 
Rhizoctonia solani,Fusarium oxysporum and Colletotrichum capsicum strains of 
Phytopathogenic fungi and they also tasted that α,β-dibromo-3,3’-dixitro-chalcone had antifungal 
activity against  three fungi with MIC=6.25µM/ml and 4-4
’
-dimethylchalcone showed activity 
against C.capsicum whose MIC =6.25µM/ml.   
O
HO O
OH
 
Figure 14 Crotmadine 
Crotmadine was present in leaves and stems of Crotalaria madurensis
49
.  It exhibited antifungal 
activity against T. mentagrophytes at a concentration of 62.5µg/ml . Jayasinghe et al. showed 
that chalcone derivatives were isolated from Artocapus nobilis.  It showed very good activity 
against Cladosporium cladosporioides having MIC values range 2-15 µg/spot.Okunade showed 
23 
 
that biological selection of dihydrochalcone derivatives were established relatively good activity 
against the acid-fast bacterium Mycobacteria intracellulare.   
2’,4’,6’-trihydroxy-3’-methyldihydrochalcone showed good activity against B.subtilis and T. 
mentagrophytes at 60µg/disk.  
50 
 
1.5.5. ANTI-VIRAL ACTIVITY:-  
The antiviral properties of chalcone depends on specific substitution patterns.  Onyilagha et al
51-
52
 looked into the hydroxyl and methoxy substituted chalcones derivatives for antiviral activity 
against tomato ring-spot nepovirus (ToRSV) infectively.  Chalcone showed antiviral activity of 
hydroxylation of ring B at 2’,3’,4’,position and c-4 position of ring A against ToRSV.  C-5 
hydroxylated chalcones did not show any antiviral activities.  The antiviral activity of chalcones 
were obviously lost when they were applied before or after ToRSV infection. Some important 
effective inhibitory compounds were
O
R2
R1
18 => R1, R2 = H; R3 = OCH3
19 => R1, R2 = OH; R3 = OCH3
R3
OOH
20 => R1, R2 = OH
21 =>R1 = H; R2 = OCH3
R2
HO
R1
OCH3
OCH3
 
Figure 15 
Acquired immunodeficiency syndrome (AIDS),a life threatening problem which is caused by 
HIV virus since 1980 and flavonoids have been investigated for anti HIV activity.  Wang et 
al.tasted that Xanthohumol was an important selective inhibitor of HIV-1 and it may represent a 
novel therapeutic agent for HIV-1 infection
53
.  The EC50
’
s of Xanthohumol on reducing p24 
antigen and RT production were 1.28 µg/ml.
54
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Figure 16 Xanthohumol 
 
It also reduced HIV-1 replication in peripheral blood mononuclear cells (PBMC) infected with 
HIV-1IIIB, and the EC50 of Xanthohumol for reducing p29 antigen production was 20.74µg/ml.   
O
H3CO
CHO
H3C
OH
OH  
Figure 17 
Wu and colleagues reported  chalcone 17 from genus Desmos showed potent anti-HIV activity 
with a good therapeutic inden
55
.   
The reducing activity of Butein and Phloretin on HIV-1 protease was tasted by Xu et. al. using 
fluorescence and HPLC assays . According to their analysis it has been reported that at 50µg/ml 
concentration.  Butein showed 50% inhibition where as for Phloretin it was only 27%. 
25 
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Figure 18 Butein 
3,3
’
,4,4
’
-tetrahydroxy-2-methoxy chalcone had a negative effect on HIV transcription because 
they bind to some specific protein factors.
56
   
Cardamonin showed an important anti-HIV-1 PR activity with IC50 value of 31 µg/ml.   
O
OH
OH
OCH3
 
Figure 19 Cardamonin 
 
1.5.6. ANTI-INFLAMMATORY ACTIVITY:- 
Herencia et. Al
57
. reported a series of chalcone derivatives for possible anti-inflammatory effect 
.23 worked as a scavenger of superoxide anion generated by stimulated human neutrophilsor by 
the hypoxanthine / xanthine oxidase system with IC50=0.1 and 0.3 µM respectively.   
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Chapter 2 
Ferrocenyl and cymantrenyl chalcones: 
Synthesis and Characterization 
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2.1. Introduction 
Recently, synthesis of ferrocenyl chalcones have been extensively focused for their 
interesting biological properties and for their use as precursor for various other important 
molecules.  Both ferrocene and chalcones have been separately known to form a large number of 
derivatives which not only shows potential biological properties but also various other 
optoelectronics and electrochemical properties.  It has been recently explored that Incorporation 
of three dimensional ferrocenyl groups instead of flat aryl substitutent into the chalcon moiety 
can results in favorable change in biological and other properties.  
Recently some research groups synthesized formylcymantrene(A), cyanocymantrene(B), 
cymentrenyl methyl imidate from cymentrene [(η5-cyclopentadienyl)tricarbonyl manganese] 
(scheme  7).
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Scheme 7 
Bovin Serum Albumin (protein) used for labeling assays because it is inexpensive and easily 
available.  This protein in borate buffer PH 9.0 was be treated with different quantities of C 
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dissolved in MeOH. (scheme 8) 
Mn
OC
CO
CO
NH
OMe
Mn
OC
CO
CO
C
P
NH2
NH2
NH2H2N
H2N NH2
P
NH2
H2N
H2N NH2
N
NH2+
 
Scheme 8 
Recently S.-K et.al.synthesized ferrocenyl chalcone with two pyrenyl groups (Figure 21).  Di-
pyrenyl compounds readly form an excimer intramolecularly and this type of compounds also 
have on-off switchable chemosensor properties towords specific anions or cations.  
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Figure 21 
2.2 Experimental Sections 
2.2.1 General Procedures 
All reactions and manipulations were carried out under an inert atmosphere of dry, pre-purified 
argon using standard schlenk line techniques.  Solvents were purified, dried and distilled under 
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argon atmosphere prior to use.  Infrared spectra were recorded on a Perkin Elmer Spectrum RX-I 
spectrometer as dichloromethane solutions in 0.1 mm path lengths NaCl cell and NMR spectra 
on a 400 MHz Bruker spectrometer in CDCl3.  TLC plates (20x20 cm, Silica gel 60 F254) were 
purchased from Merck.  [CpMn(CO)3], Ferrocene were purchased from Sigma Aldrich. 
2.2.1. Synthesis of Monoaldehyde ferrocene (1) 
 2.79 gm of ferrocene (0.015 mole) was dissolved in 12ml of chloroform with continous 
stirring in room temperature under N2 atmosphere and the mixture turned into a dark brown 
coloured solution.  In another round bottom flask, DMF was taken in an ice bath and to it POCl3 
was added in small portion with stirring.  Then the mixture of DMF and POCl3 was added to the 
ferrocene solution keeping the solution in an ice bath for 10 mins.  The ice bath was removed 
and the whole mixture with some brown precipitate was refluxed in an oil bath with continous 
stirring for 6 hours.  Then it was separated in a separating funnel using ice and distilled water 
and filtered.  The combined organic layers were dried in rotavapor.  The reaction mixture was 
dissolved in dichloromethane and subjected purification by Thin Layer Chromatography using 
pet-ether and ethylacetate solution mixtures (10:1).  
1: IR(CO, cm
-1
,CH2Cl2) 1652 
 
2.2.3. Synthesis of Acetyl cymantrene (2) 
 A 100 ml two necked flask equipped with glass stoppers, magnetic stirring bar was 
connected with a nitrogen cylinder. In this flask 2.4 g (0.01 moles) of cymantrene was taken and 
then to it 25 ml of CH2Cl2 quickly poured. To the stirring solution of cymantrene, 1.5 ml (0.019 
moles) of acetyl chloride was added drop wise from the syringe.  The stirred reaction mixture 
was cooled in the ice bath for 15 minutes then 2.5 g (0.019 moles) of anhydrous AlCl3 was 
added in small portions during 15 minutes , the cooling bath was removed and the reaction 
mixture was stirred for additional 30 minutes at room temperature. The color of the reaction 
mixture immediately transformed to dark yellowish brown. 
The formation of the monoacetyl derivative of cymantrene was checked by Thin Layer 
Chromatography (using CH2Cl2 / hexane in 1:1 ratio).  The reaction mixture was then poured on 
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50 g of crashed ice in 50 ml of water in the beaker.  The flask was then rinsed with small 
amount of CH2Cl2 and the combined layers were transferred into a separatory funnel.  The 
organic layer contained the desired product monoacetyl cymantrene and was extracted with 
CH2Cl2 .  The combined organic layers were extracted twice with water and then finally dried to 
obtain the monoacetyl cymantrene for further ligand synthesis. The chemical equation is given 
in Scheme 9. 
1: IR(CO, cm
-1
,CH2Cl2) 1729 (vs), 1932.5 (vs, br), 2025.4 (vs) 
 
 
2.3 RESULTS AND DISCUSSION  
 Monoferrocenyl aldehyde (1) has been prepared from the reaction of ferrocene with 
POCl3 in dimethylformamide solvent.  The compound was purified by column chromatography 
using Ethylacetate/ pet ether solvent mixture. 
 
Fe
Fe H
0
+ DMF  +  POCl3
Stirr, Reflux, N2
6 hours
1  
Scheme 9 
 
Room temperature reaction of [CpMn(CO)3] with acetyl chloride in presence of AlCl3 lead to the 
formation of a yellow colored acetyl cymantrene (2) in almost 90 % yield ( Scheme 10).  
Compound 2 was isolated by column chromatography using pet ether /dichloromethane solvent 
mixture and spectroscopic characterization was performed to predict the compound. 
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FTIR spectra for both the compounds 1 and 2 reveals the presence of ketonic C=O groups at 
1678 cm
-1
 and metal carbonyl in the region 2025-1933 cm
-1
 for compound 2.   
  
 
2.4 CONCLUSION  
Acetyl cymantrene [(5-C5H4)Mn(CO)3] on reaction with monoaldehyde ferrocene [(
5
C5H4)Fe-
(5C5H5)CHO] led to the formation of a bimetallic chalcone 
[(5C5H4)Mn(CO)3}COCH=CH}([(
5
-C5H4)Fe(
5
C5H4)}] (3).  Tentative structure of compound 
3 has been predicted from the spectroscopic characterization which reveals the presence of 
ferrocenyl and cymantrenyl moiety in the two end of a chalcone.  
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Annexure 
FTIR Spectra of FcCHO (1) 
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FTIR Spectra of CpMnCOCH3 (2) 
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